Watchlist Price Alert

Oncternal Therapeutics In... (ONCT)

NASDAQ: ONCT · Real-Time Price · USD

0.53

-0.16 (-23.63%)

At close: Dec 02, 2024, 9:00 PM

Oncternal Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-39.48M	-44.17M	-31.33M	-17.23M	-34.19M	-38.42M	-30.44M	-17.72M
Depreciation & Amortization	n/a	-75K	169K	150K	n/a	46K	47K	28K
Stock-Based Compensation	7.5M	7.43M	5.88M	1.56M	507K	2.2M	3.15M	2.96M
Other Working Capital	3.04M	-1.03M	-2.12M	-1.95M	2.25M	-4.01M	2.23M	1.15M
Other Non-Cash Items	-1.46M	179K	169K	-151K	19.45M	166K	166K	132K
Deferred Income Tax	n/a	n/a	-169K	-150K	n/a	n/a	n/a	-8.16M
Change in Working Capital	1.27M	-69K	-1.3M	-1.68M	-2.51M	-3.34M	3.62M	1.99M
Operating Cash Flow	-32.16M	-36.7M	-26.59M	-17.5M	-16.75M	-39.35M	-23.46M	-20.78M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	-2K	-90K
Cash Acquisitions	n/a	n/a	n/a	n/a	16.14M	n/a	-24.16M	-37.65M
Purchase of Investments	-64.35M	-26.5M	n/a	n/a	n/a	-44.16M	-39.28M	-35.4M
Sales Maturities Of Investments	65M	n/a	n/a	n/a	n/a	72.04M	24.16M	37.65M
Other Investing Acitivies	n/a	-26.5M	n/a	n/a	-2.15M	72.04M	24.16M	37.65M
Investing Cash Flow	651K	-26.5M	n/a	n/a	16.14M	27.88M	-15.13M	2.15M
Debt Repayment	n/a	n/a	n/a	301K	n/a	n/a	n/a	n/a
Common Stock Repurchased	-156K	-3K	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	617K	4K	15K	-569K	-156K	-211K
Financial Cash Flow	1.07M	9.58M	617K	114.18M	15K	23.91M	45.49M	13.48M
Net Cash Flow	-30.45M	-53.62M	-25.97M	96.69M	-594K	12.44M	6.91M	-5.15M
Free Cash Flow	-32.16M	-36.7M	-26.59M	-17.5M	-16.75M	-39.35M	-23.46M	-20.87M